Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 1, 2003, Pages 59-68

  Arias, C A ^a,b   Reyes, J ^a   Zuniga M ^a   Cortes L ^a   Cruz, C ^a   Rico, C L ^b   Panesso, D ^a   Gutiérrez, Mónica ^c   de Merino, Nohra ^c   Pacheco, Gloria ^c   Sussman, Otto ^c   Moncada, Diana ^c   Quevedo, Ruth ^c   Arroyo, Patricia ^c   Garzón, Martha ^c   Saavedra, Carlos ^c   de Otero, Amparo ^c   Martínez, Oscar ^c   Torrado, Edilma ^c   Tobón Uribe, Pablo ^c   López, Jaime ^c   Rodríguez, Mauricio ^c   Villar, Luis Angel ^c   Gallardo, Luz M ^c   Martínez, Ernesto ^c   del Pilar Crespo, Ma ^c   Velez, Juan D ^c   Vanegas, Beatriz ^c   Villegas, Maria V ^c   Cardona, Gloria ^c   Mendoza, Mario ^c   Perez, Carlos ^c   more..

^a UNIVERSIDAD EL BOSQUE   (Colombia)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN SANTA FE DE BOGOTÁ   (Colombia)

^c NONE

Author keywords

Colombia; Enterococci; Resistance; Staphylococci

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; METICILLIN; OXACILLIN; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLOMBIA; CONTROLLED STUDY; DILUTION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HEALTH CENTER; HUMAN; INFUSION SYSTEM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COLOMBIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; HUMANS; MICROBIAL SENSITIVITY TESTS; PATIENT ADMISSION; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 12244265489     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg002     Document Type: Article

References (34)

1. Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L. et al. (2001). Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358, 207-8.
2. Hiramatsu, K. (1998). Vancomycin resistance in staphylococci. Drug Resistance Updates 1, 135-50.
3. Murray, B. E. (2000). Vancomycin-resistant enterococcal infections. New England Journal of Medicine 342, 710-20.
4. Gonzalez, R., Schreckenberger, P., Graham, M., Kelkar, S., DenBesten, K. & Quinn, J. P. (2001). Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357, 1179.
5. Linden, P. K., Moellering, R. C., Wood, C. A., Relm, S. J., Flaherty, J., Bampart, F. et al. (2001). Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin. Clinical Infectious Diseases 33, 1816-23.
6. Haroche, J., Allignet, J. & Solh, E. N. (2002). Tn5406, a new staphylococcal transposon conferring resistance to streptogramin and related compounds including dalfopristin. Antimicrobial Agents and Chemotherapy 46, 2337-43.
7. Singh, K. V., Weinstock, G. M. & Murray, B. E. (2002). An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrobial Agents and Chemotherapy 46, 1845-50.
8. Archer, G. L. & Niemeyer, D. M. (1994). Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends in Microbiology 2, 343-7.
9. Musser, J. M. & Kapur, V. (1987). Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. Journal of Clinical Microbiology 30, 2058-63.
10. Centinkaya, Y., Falk, P. & Mayhall, C. G. (2000). Vancomycin-resistant enterococci. Clinical Microbiology Reviews 13, 686-707.
11. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Susceptibility Testing: M-100-S8. NCCLS, Villanova, PA, USA.
12. Low, D. E., Keller, N., Barth, A. & Jones, R. (2001). Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clinical Infectious Diseases 32, Suppl. 2, S133-45.
13. Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A. et al. (1998). Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. Journal of Clinical Microbiology 36, 1020-7.
14. Martineau, F., Picard, F. J., Lansac, N., Menard, C., Roy, P. H., Ouellette, M. et al. (2000). Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 44, 231-8.
15. Dutka-Malen, S., Evers, S. & Courvalin, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology 33, 24-7.
16. Woodford, N., Egelton, C. M. & Morrison, D. (1997). Comparison of PCR with phenotypic methods for the speciation of enterococci. Advances in Experimental Medicine 418, 405-8.
17. Panesso, D., Ospina, S., Robledo, J., Vela, M. C., Peña, J., Hernández, O. et al. (2002). First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium in a Colombian hospital. Emerging Infectious Diseases 8, 961-5.
18. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. A., Persing, D. H. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
19. Lowy, F. D. (1998). Staphylococcus aureus infections. New England Journal of Medicine 339, 520-32.
20. Hunter, P. A. & Reeves, D. S. (2002). The current status of surveillance of resistance to antimicrobial agents: report on a meeting. Journal of Antimicrobial Chemotherapy 49, 17-23.
21. Lewis, D. (2002). Antimicrobial resistance surveillance: methods will depend on objectives. Journal of Antimicrobial Chemotherapy 49, 3-5.
22. Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N. et al. (2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases 32, Suppl. 2, S114-32.
23. Andrews, J., Ashby, J., Jevons, G., Marshall, T., Lines, N. & Wise, R. (2000). A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1998. Journal of Antimicrobial Chemotherapy 45, 285-93.
24. Henwood, C. J., Livermore, D. M., Johnson, A. P., James, D., Warner, M., Gardiner, A. et al. (2000). Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. Journal of Antimicrobial Chemotherapy 46, 931-40.
25. Markowitz, N., Quinn, E. & Saravolatz, L. D. (1992). Trimethoprim-sulphamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Annals of Internal Medicine 117, 390-8.
26. Oliveira, G. A., Dell'Aquila, A. M., Masiero, R. L., Levy, C. E., Gomes, M. S., Cui, L. et al. (2001). Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infection Control and Hospital Epidemiology 7, 443-8.
27. Gomes, A. R., Santos I., Aires de Sousa, M., Castañeda, E. & de Lencastre H. (2001). Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Colombian hospitals: dominance of a single unique multidrug-resistant clone. Microbial Drug Resistance 7, 23-32.
28. Proctor, R. (2000). Coagulase-negative staphylococcal infections: a diagnostic and therapeutic challenge. Clinical Infectious Diseases 31, 31-3.
29. Brandt, C. M., Rouse, M. S., Tallan, B. M., Laue, N. W., Wilson, W. R. & Steckelberg, J. M. (1995). Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant β-lactamase-producing coagulase-negative staphylococcal experimental endocarditis. Antimicrobial Agents and Chemotherapy 39, 1815-9.
30. Zimmerli, W., Widmer, A. F., Blatter, M., Frei, R. & Ochsner, P. E. (1998). Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. Journal of the American Medical Association 279, 1537-41.
31. Norris, A. H., Reilly, P. H., Edenstein, P. H., Brennon, P. J. & Schuster, M. G. (1995). Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clinical Infectious, Diseases 20, 1137-44.
32. Papanicolaou, G. A., Meyers, B. R., Meyers, J., Mendelson, M. H., Lou, W., Emre, S. et al. (1996). Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clinical Infectious Diseases 23, 760-6.
33. Safdar, A., Bryan, C., Stinson, S. & Saunders, D. (2002). Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline. Clinical Infectious Diseases 34, 61-3.
34. Jones, R. N., Della-Latta, P., Lee, L. V. & Biedenbach, D. J. (2002). Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from SENTRY Antimicrobial Surveillance Program. Diagnostic Microbiology and Infectious Disease 2, 137-9.